Description of a practice model for pharmacist medication review in a general practice setting

  • Mette Brandt
  • Jesper Hallas
  • Trine Graabæk
  • Anton Pottegård
Keywords: Pharmaceutical Services, Professional Practice, Pharmacists, General Practitioners, Drug-Related Side Effects and Adverse Reactions, Drug Therapy, Denmark


Background: Practical descriptions of procedures used for pharmacists’ medication reviews are sparse.

Objective: To describe a model for medication review by pharmacists tailored to a general practice setting.

Methods: A stepwise model is described. The model is based on data from the medical chart and clinical or laboratory data. The medication review focuses on the diagnoses of the patient instead of the individual drugs. Patient interviews are not part of the model. The model was tested in a pilot study by conducting medical reviews on 50 polypharmacy patients (i.e. receiving 7 or more drugs for regular use).

Results: The model contained seven main steps. Information about the patient and current treatment was collected in the first three steps, followed by identification of possible interventions related to either diagnoses or drugs in the fourth and fifth step. The sixth and seventh step concerned the reporting of interventions and the considerations of the GPs. 208 interventions were proposed among the 50 patients. The acceptance rate among the GPs was 82%. The most common interventions were lack of clinical or laboratory data (n=57, 27%) and drugs that should be discontinued as they had no indication (n=47, 23%). Most interventions were aimed at cardiovascular drugs.

Conclusion: We have provided a detailed description of a practical approach to pharmacists’ medication review in a GP setting. The model was tested and found to be usable, and to deliver a medication review with high acceptance rates. 


Download data is not yet available.


1. National Prescribing Centre. A guide to medication review. Available from: (Accessed 9/11/2012).

2. Blenkinsopp A, Bond C, Raynor DK. Medication reviews. Br J Clin Pharmacol. 2012;74(4):573-580. doi: 10.1111/j.1365-2125.2012.04331.x

3. Cipolle RJ, Strand LM, Morley P. Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management. Third Edition ed. 2012. McGraw Hill Professional:

4. Graabaek T, Kjeldsen LJ. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol. 2013;112(6):359-373. doi: 10.1111/bcpt.12062

5. Thomsen LA, Herborg H, Rossing C. Modeller for medicingennemgang i den danske primære sundhedssektor [Models for medication review in the Danish primary health sector]. Version 1.1 ed. 2011. Pharmakon:

6. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72-83.

7. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen HJ, Feussner JR. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045-1051.

8. Dansk Cardiologisk Selskab. NBV11 Den Nationale Kardiologiske Behandlingsvejledning, Maj 2011 [The National Cardiology Guideline]. Available from: (Accessed 23/4/2012).

9. Bang L, Bruun N, Christensen K, Ibsen H, Svendsen T. Hypertensio arterialis - behandlingsvejledning [Hypertensio Arterialis - Treatment Guideline]. Dansk Hypertensionsselskab; 2009.

10. Dansk Selskab for Almen Medicin. Klinisk Vejledning for Almen Praksis. Angsttilstande [Anxiety disorders]. 2010.

11. Dansk Selskab for Almen Medicin. Klinisk Vejledning for Almen Praksis. Unipolar Depression. [Unipolar Depression]. 2010.

12. Dansk Selskab for Almen Medicin. Klinisk Vejledning for Almen Praksis. Udredning og behandling af nedre urinvejssymptomer hos mænd og kvinder [Elucidation and treatment of lower urinary symptoms among male and female]. 2009.

13. Dansk Selskab for Almen Medicin. Klinisk Vejledning for Almen Praksis. Dyspepsi [Dyspepsia]. 2009.

14. Dansk Selskab for Almen Medicin. Klinisk Vejledning for Almen Praksis. KOL i almen praksis [COPD in general practice]. 2008.

15. Dansk Selskab for Almen Medicin. Klinisk Vejledning for Almen Praksis. Guidelines for type 2-diabetes [Guidelines for type-2 diabetes]. 2011.

16. Porsbjerg C, Siersted H, Sidenius K, Hilberg O, Backer V. Astma: Behandling. [Asthma: Treatment]. Dansk Lungemedicinsk Selskab; 2009.

17. Dansk Selskab for Apopleksi. Referenceprogram for behandling af patienter med apopleksi [Guideline for treatment of patients with apoplexy]. 2009.

18. Dansk Knoglemedicinsk Selskab. Vejledning til udredning og behandling af osteoporose [Guideline for elucidation and treatment of osteoporosis]. 2009.

19. Institut for Rationel Farmakoterapi. Anmeldelser [Drug Reviews]. Available from: (Accessed 18/7/2012).

20. Institut for Rationel Farmakoterapi. National Rekommandationsliste [National Recommendation List]. Available from: (Accessed 24/4/2012).

21. European Medicines Agency. Summary of Product Characteristics (SPC). Available from: (Accessed 26/6/2013).

22. Institut for Rationel Farmakoterapi. Benzodiazepin-nedtrapningsskemaer til praktiserende læger, praksismedarbejdere og patienter [A scheme for gradual reduction of benzodiazepines in general practice]. Available from: (Accessed 14/5/2012).

23. Institut for Rationel Farmakoterapi. Seponering [Drug Discontinuation]. Available from: (Accessed 24/4/2012).

24. WHO Collaborating Centre for Drug Statistics Methodology. Structure and principles. Available from: (Accessed 18/7/2012).

25. Glintborg D. Medicingennemgang i almen praksis [Medication Review in General Practice]. Månedsskrift for Almen Praksis 2011;89:5-10.

26. Lowe CJ, Petty DR, Zermansky AG, Raynor DK. Development of a method for clinical medication review by a pharmacist in general practice. Pharm World Sci. 2000;22(4):121-126.

27. Chen TF, de Almeida Neto AC. Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review. Pharm World Sci. 2007;29(6):574-576.

28. Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysis. Am J Health Syst Pharm. 2011;68(3):241-253. doi: 10.2146/ajhp090656

29. O'Mahony D, Gallagher P, Ryan C, Byrne S, Hamilton H, Barry P, O’Connor M, Kennedy J. STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age. Eur Geriatr Med. 2010;1(1):45-51.

30. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616-631. doi: 10.1111/j.1532-5415.2012.03923.x
How to Cite
Brandt M, Hallas J, Graabæk T, Pottegård A. Description of a practice model for pharmacist medication review in a general practice setting. Pharm Pract (Granada) [Internet]. 2014Sep.4 [cited 2019Aug.19];12(3):420. Available from:
Original Research